Filter
413
Text search:
Saudi
Arabia
Featured
Recommendations
33
New Publications
79
Language
Document type
No document type
183
Studies & Reports
122
Guidelines
45
Strategic & Response Plan
18
Situation Updates
13
Manuals
11
Fact sheets
10
Training Material
4
Resource Platforms
4
Infographics
2
Videos
1
Countries / Regions
Global
48
Yemen
36
Syria
20
Middle East and North Africa
19
Saudi Arabia
18
South Sudan
12
Somalia
10
Mali
9
Ethiopia
9
Egypt
9
Sudan
8
Niger
7
South Africa
7
Africa
7
Iraq
6
Jordan
6
Kenya
6
Pakistan
5
Lebanon
5
Chad
5
Djibouti
5
Nigeria
4
Morocco
4
India
4
Afghanistan
4
Bangladesh
4
Libya
4
Myanmar / Burma
4
East and Southern Africa
4
West and Central Africa
4
Asia
4
Palestine
4
Russia
4
Tunisia
4
Burkina Faso
3
Uganda
3
Cambodia
3
China
3
Indonesia
3
Mozambique
3
Brazil
3
Sierra Leone
2
Congo, Democratic Republic of
2
Philippines
2
Nepal
2
Germany
2
Thailand
2
Mauritania
2
Greece
2
Mexico
2
South–East Asia Region
2
Latin America and the Carribbean
2
Western and Central Europe
2
Qatar
2
Iran
2
Guinea
1
Liberia
1
Ghana
1
Haiti
1
Rwanda
1
Malawi
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Burundi
1
Ecuador
1
Botswana
1
Angola
1
Eastern Europe and Central Asia
1
Venezuela
1
Eastern Europe
1
Albania
1
Armenia
1
Laos
1
Georgia
1
Vietnam
1
Portugal
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
100
Public Health
40
Clinical Guidelines
37
Women & Child Health
20
Key Resources
13
Capacity Building
6
Pharmacy & Technologies
3
Protection & Security
1
Toolboxes
COVID-19
65
Mental Health
46
Conflict
22
Refugee
18
AMR
18
Rapid Response
17
HIV
16
NTDs
16
Health Financing Toolbox
16
TB
13
Planetary Health
13
NCDs
13
Disability
8
Global Health Education
8
Ebola
7
Caregiver
7
Pharmacy
7
Polio
5
Zika
3
Specific Hazards
3
Cholera
2
Natural Hazards
1
Social Ethics
1
Patient safety assessment manual
recommended
3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO gu
...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance
...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov
...
The HHFA Comprehensive guide serves as the main reference document for planning and implementing a country HHFA. This guide will promote understanding of:
What the HHFA is and the information it can and cannot provide.
The HHFA modules, questionnaires and CSPro electronic data collection tool.
Th
...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first
...
Trachoma, caused by particular serovars of Chlamydia trachomatis, is the leading
infectious cause of blindness. Infection is transmitted within ocular and nasal secretions that are passed from person to person on fingers, fomites (such as clothing) and eye-seeking flies (particularly Musca sorbens)
...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t
...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm
...
Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode
worms) of the genus Schistosoma. At least 249 million people required preventive treatment in
2012. Preventive treatment, which should be repeated over a number of years, will reduce and
prevent morbidity.
...
The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of
recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac
...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics
...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported
...
Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A
...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af
...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re
...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines
...
